share_log

BTIG Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $16

BTIG Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $16

BTIG以买入评级启动ProKidny的保险,宣布目标股价为16美元
Benzinga ·  2023/07/25 04:32

BTIG analyst Justin Zelin initiates coverage on ProKidney (NASDAQ:PROK) with a Buy rating and announces Price Target of $16.

BTIG分析师贾斯汀·泽林在ProKidney(纳斯达克:PROK)上以买入评级启动报道,并宣布目标价为16美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发